Function
Locations
Hydrolyses dUTP to dUMP + PPi (nuclear and mitochondrial isoforms), preventing mutagenic uracil misincorporation into DNA and feeding dUMP to thymidylate synthase.
Thymidylate synthesis is the route that makes the DNA-specific precursor dTTP, distinguishing DNA (thymine) from RNA (uracil) precursors. dUTP diphosphatase (DUT) hydrolyses dUTP to dUMP + diphosphate, which both keeps the cellular dUTP:dTTP ratio low (preventing mutagenic uracil misincorporation into DNA) and supplies dUMP as substrate. Thymidylate synthase (TYMS) then reductively methylates dUMP to dTMP, using 5,10-methylenetetrahydrofolate as the one-carbon donor (oxidised to dihydrofolate, regenerated by DHFR) — the sole de novo source of dTMP. Thymidylate kinase (DTYMK) phosphorylates dTMP to dTDP, the essential step common to both the de novo and salvage routes; nucleoside diphosphate kinase then makes dTTP. This pathway is a central target of chemotherapy — TYMS is inhibited by the 5-fluorouracil metabolite FdUMP and by antifolates (raltitrexed, pemetrexed), and the folate cofactor supply is targeted by methotrexate — because rapidly dividing cells depend on de novo dTTP for DNA replication. Perturbing the balance (e.g. DUT loss, TYMS inhibition) causes dUTP accumulation, uracil misincorporation and DNA damage.
All recommended fields populated.
✗ none found
No MODULE:thymidylate_synthesis deep-research report alongside the module YAML.
✓ every leaf node grounds to a representative protein.
✓ every declared conforms_to bundle matches its template motif.
3 complete review(s) · 0 with deep research · 0 missing review · 3 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| DTYMK P23919 | ✓ | ✓ | ✗ |
| DUT P33316 | ✓ | ✓ | ✗ |
| TYMS P04818 | ✓ | ✓ | ✗ |
Thymidylate (dTMP -> dTTP) synthesis grounded to the human enzymes DUT (UniProtKB:P33316, GO:0004170, EC 3.6.1.23), thymidylate synthase TYMS (P04818, GO:0004799, EC 2.1.1.45) and thymidylate kinase DTYMK (P23919, GO:0004798, EC 2.7.4.9). GO molecular-function terms were taken from the human GOA records; Reactome reaction ids and titles were verified against the local reactome cache. Each step uses a PANTHER family selector (generic over orthologs) with the human enzyme as representative. The pathway converts dUTP -> dUMP -> dTMP -> dTDP, with dTDP then phosphorylated to dTTP by nucleoside diphosphate kinase (NME family, not modelled here). It is tightly coupled to folate one-carbon metabolism (TYMS consumes 5,10-methylene-THF and releases DHF, regenerated by DHFR) and is the pre-eminent antiproliferative drug target: 5-fluorouracil (via FdUMP) and antifolates (raltitrexed, pemetrexed) inhibit TYMS, and methotrexate depletes the folate cofactor. dUMP also arises by salvage/deamination routes, and dTMP by thymidine salvage (TK1/TK2), which feed the same DTYMK step. Loss of the dUTPase gate (DUT) or TYMS inhibition raises dUTP and causes uracil misincorporation / DNA damage. Disease relevance is largely pharmacologic/pharmacogenetic; DTYMK has been linked to a severe neurodevelopmental disorder.
Hydrolyses dUTP to dUMP + PPi (nuclear and mitochondrial isoforms), preventing mutagenic uracil misincorporation into DNA and feeding dUMP to thymidylate synthase.
Homodimer catalysing the sole de novo source of dTMP; couples to folate one-carbon metabolism (produces DHF, regenerated by DHFR). Central 5-FU/ antifolate chemotherapy target; autoregulates its own translation.
Phosphorylates dTMP to dTDP — the rate-limiting step common to both the de novo (TYMS) and salvage (thymidine kinase) routes to dTTP; essential for DNA replication. dTDP is then converted to dTTP by nucleoside diphosphate kinase.